Literature DB >> 8035399

A randomized, controlled clinical trial of education and physical training for women with fibromyalgia.

C S Burckhardt1, K Mannerkorpi, L Hedenberg, A Bjelle.   

Abstract

OBJECTIVE: To determine the effectiveness of self-management education and physical training in decreasing fibromyalgia (FMS) symptoms and increasing physical and psychological well being.
METHODS: A pretest-posttest control group design was used. Ninety-nine women with FMS were randomly assigned to 1 of 3 groups; 86 completed the study. The education only group received a 6-week self-management course. The education plus physical training group received the course and 6 h of training designed to assist them to exercise independently. The control group got treatment after 3 months.
RESULTS: The experimental programs had a significant positive impact on quality of life and self-efficacy. Helplessness, number of days feeling bad, physical dysfunction, and pain in the tender points decreased significantly in one or both of the treated groups when retested 6 weeks after the end of the program. Longterm followup of 67 treated subjects showed significant positive changes on the Fibromyalgia Impact Questionnaire primarily in the physical training group. Among all subjects, 87% were exercising at least 3 times/week for 20 min or more; 46% said they had increased their exercise level since participating in the program; 70% were practicing relaxation strategies as needed; 46% were working at least half time as opposed to 37% at pretest.
CONCLUSION: Self-efficacy of the treated groups was enhanced significantly by the program. Other changes were smaller and more delayed than had been expected. Recommendations for future trials include a longer education program, more vigorous physical training, and longterm followup.

Entities:  

Mesh:

Year:  1994        PMID: 8035399

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  54 in total

1.  [Patient education: cui bono?].

Authors:  E Genth
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

2.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  [Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Häuser; E Felde; C Flügge; R Häfner; M Settan; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 4.  Chronic pain syndromes.

Authors:  S Carette
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 5.  A realistic approach to managing patients with fibromyalgia.

Authors:  Geoffrey O Littlejohn; Janine Walker
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

6.  Effects of muscle strengthening versus aerobic exercise program in fibromyalgia.

Authors:  Ciğdem Bircan; Seide Alev Karasel; Berrin Akgün; Ozlem El; Serap Alper
Journal:  Rheumatol Int       Date:  2007-11-03       Impact factor: 2.631

7.  The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.

Authors:  Lene Thorsen; Wenche Nystad; Hein Stigum; Olav Dahl; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Sophie D Fosså
Journal:  Support Care Cancer       Date:  2005-03-09       Impact factor: 3.603

8.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 9.  Pharmaceutical treatment options for fibromyalgia.

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

10.  The feasibility and efficacy of a multidisciplinary intervention with aftercare meetings for fibromyalgia.

Authors:  Mariëlle Kroese; Guy Schulpen; Monique Bessems; Frans Nijhuis; Johan Severens; Robert Landewé
Journal:  Clin Rheumatol       Date:  2009-05-05       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.